NCT07168993 2026-03-18
BA-004
bioAffinity Technologies Inc.
Phase NA Recruiting
Clinical Trials
1,045 trialsNCT07480902 2026-03-18
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Timser SAPI de CV
Phase NA Recruiting
NCT05149755 2026-03-17
Evolut™ EXPAND TAVR II Pivotal Trial
Medtronic Cardiovascular
Phase NA Active not recruiting
NCT05601323 2026-03-16
A Study of Suizenji in Patients With Unresectable Pancreatic Cancer
SONIRE Therapeutics Inc.
Phase NA Active not recruiting
NCT05764720 2026-03-16
ARTIA-Pancreas
Varian, a Siemens Healthineers Company
Phase NA Recruiting
NCT06651632 2026-03-16
WATER IV PCa
PROCEPT BioRobotics
Phase NA Recruiting
NCT07130682 2026-03-16
PT2
Hong Kong Sanatorium & Hospital
Phase NA Recruiting
NCT06681233 2026-03-13
Feasibility Study of CBCT for IGRT in Cancer Patients
Varian, a Siemens Healthineers Company
Phase NA Recruiting
NCT04905069 2026-03-12
SABRE
Boston Scientific Corporation
Phase NA Active not recruiting
NCT06085833 2026-03-12
ANGEL
ARTIDIS AG
Phase NA Recruiting
NCT06451614 2026-03-12
HYDROSPACE
Boston Scientific Corporation
Phase NA Active not recruiting
NCT06511141 2026-03-12
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Axonics, Inc.
Phase NA Recruiting
NCT07003841 2026-03-12
Evaluation of Clinical Efficacy of Augmented Reality (AR)-Based Breast Cancer Medical Imaging Solution (SKIA-Breast) Localization Method in Breast Cancer Patients
SKIA Inc.
Phase NA Recruiting
NCT07465796 2026-03-12
CIPHER
Coherence Neuro Australia Pty Limited
Phase NA Not yet recruiting
NCT06765590 2026-03-09
Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase NA Recruiting
NCT06919809 2026-03-09
Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery
McGuire Institute
Phase NA Completed
NCT06039644 2026-03-06
To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer
GenMont Biotech Incorporation
Phase NA Recruiting
NCT06340815 2026-03-06
Varian ProBeam Proton Therapy System Clinical Trial (Shandong)
Varian, a Siemens Healthineers Company
Phase NA Completed
NCT06564233 2026-03-06
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
Friendi.fi Corporation
Phase NA Recruiting
NCT06985238 2026-03-06
Stratagen Quantitative Prostate MRI Platform Pilot Study
Stratagen Bio, Inc.
Phase NA Recruiting
NCT07120945 2026-03-06
Embrace Gyn
Medtronic - MITG
Phase NA Recruiting
NCT07453797 2026-03-06
VISION
Activ Surgical
Phase NA Not yet recruiting
NCT05611632 2026-03-05
NHS-Galleri
GRAIL, Inc.
Phase NA Active not recruiting
NCT06453642 2026-03-05
GPX
Fluidx Medical Technology, Inc.
Phase NA Active not recruiting
NCT06979180 2026-03-05
A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.
Papillex Inc.
Phase NA Recruiting
NCT07122258 2026-03-05
Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1
Tau-MEDICAL Co., Ltd.
Phase NA Recruiting
NCT03044054 2026-03-04
HIFU-003
Theraclion
Phase NA Completed
NCT05953337 2026-03-04
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
ABK Biomedical
Phase NA Active not recruiting
NCT07211204 2026-03-03
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
Timser SAPI de CV
Phase NA Withdrawn
NCT04797390 2026-03-02
A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema
Tactile Medical
Phase NA Completed
NCT05683691 2026-03-02
VAPOR 2
Francis Medical Inc.
Phase NA Active not recruiting
NCT07137195 2026-02-27
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)
Ion Beam Applications
Phase NA Active not recruiting
NCT06206746 2026-02-25
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
May Health
Phase NA Recruiting
NCT06654466 2026-02-25
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
Nest Genomics
Phase NA Recruiting
NCT05720039 2026-02-24
SP NSM
Intuitive Surgical
Phase NA Active not recruiting
NCT07291973 2026-02-24
AURORA
Endowave Ltd.
Phase NA Recruiting
NCT07429110 2026-02-24
ColoSeal™ ICD System Anastomotic Protection Pivotal Study
Averto Medical, Inc.
Phase NA Not yet recruiting
NCT07429799 2026-02-24
An Exploratory Study of Detection of Endometrial and Ovarian Cancers in Vaginal Samples Retrieved by the Ellele Sampling Device
Ellele Health
Phase NA Not yet recruiting
NCT05587972 2026-02-23
Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring
Carevive Systems, Inc.
Phase NA Active not recruiting
NCT05124912 2026-02-20
REMASTer: REcurrent Brain Metastases After SRS Trial
Monteris Medical
Phase NA Recruiting
NCT07377487 2026-02-20
INDIGO
Boston Scientific Corporation
Phase NA Recruiting
NCT03463954 2026-02-19
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Novian Health Inc.
Phase NA Recruiting
NCT07405138 2026-02-19
Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion
Lumenis Be Ltd.
Phase NA Not yet recruiting
NCT07116668 2026-02-18
SAFE-3CV
SafeHeal Inc
Phase NA Enrolling by invitation
NCT07276529 2026-02-17
Colonic
GI Windows, Inc.
Phase NA Recruiting
NCT07412275 2026-02-17
MILA
Koelis
Phase NA Not yet recruiting
NCT05774600 2026-02-13
Virtual Sun Safe Workplaces Ph II (SSW Works)
Klein Buendel, Inc.
Phase NA Completed
NCT06562647 2026-02-13
SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
Cell Origin Biotech (Hangzhou) Co., Ltd.
Phase NA Recruiting
NCT05448365 2026-02-12
Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid
Lo.Li.Pharma s.r.l
Phase NA Recruiting
NCT06229080 2026-02-12
SEGWAY
Next Biomedical Co., Ltd.
Phase NA Completed